influenza
respiratori
syncyti
viru
rsv
infect
respons
consider
morbid
mortal
healthcar
resourc
use
netherland
estim
age
riskgroup
specif
number
antibiot
otolog
cardiovascular
prescript
per
personyear
period
elev
activ
influenza
rsv
compar
periseason
rate
data
taken
univers
groningen
inhous
prescript
databas
wwwiadbnl
virolog
surveil
period
influenza
rsv
period
excess
antibiot
prescript
estim
age
group
age
group
year
excess
antibiot
prescript
period
elev
rsv
activ
periseason
rate
exceed
surplus
estim
influenzaact
period
periseason
rate
otolog
excess
prescript
higher
influenza
rsv
among
person
year
older
notabl
without
medic
highrisk
condit
excess
prescript
cardiovascular
medic
estim
influenza
period
approxim
also
alreadi
seen
person
age
result
may
implic
influenza
vaccin
polici
particular
extens
influenza
vaccin
group
nonelderli
adult
young
children
may
lower
excess
prescript
influenza
period
three
type
drug
prescript
investig
mani
countri
annual
influenza
vaccin
recommend
elderli
person
highrisk
medic
condit
netherland
agethreshold
vaccin
year
nonhighrisk
group
threshold
lower
includ
person
age
year
older
addit
netherland
highrisk
group
vaccin
includ
individu
suffer
chronic
condit
respiratori
diseas
cardiac
diseas
diabet
mellitu
renal
failur
immunocompromis
individu
age
less
year
age
chronic
salicyl
use
vaccin
rate
among
highrisk
group
year
age
rang
netherland
person
year
older
medic
indic
show
higher
vaccin
coverag
compar
age
without
indic
respect
influenza
may
caus
acut
bronchiti
pneumonia
highrisk
group
elderli
may
lead
exacerb
underli
chronic
medic
condit
cardiovascular
diseas
asthma
diabet
potenti
lead
hospitalis
death
prevent
influenza
infect
vaccin
high
import
group
increas
risk
complic
influenza
infect
although
countri
recommend
routin
influenza
vaccin
among
children
age
month
year
clinic
data
impact
vaccin
limit
yet
vaccin
healthi
children
age
group
could
costeffect
even
costsav
societ
set
netherland
univers
influenza
vaccin
children
debat
howev
yet
vaccin
efficaci
effect
specif
age
group
consid
suffici
demonstr
therefor
dutch
health
council
conclud
yet
start
influenza
vaccin
group
compar
conclus
made
healthi
children
age
year
older
although
vaccin
shown
effect
children
influenza
consid
caus
seriou
morbid
mortal
netherland
group
next
influenza
viru
b
respiratori
syncyti
viru
rsv
shown
caus
similar
type
complic
includ
complic
respiratori
tract
rsv
often
recogn
caus
morbid
mortal
among
children
adult
contribut
major
burden
ill
prevent
vaccin
yet
market
rsv
gener
difficult
estim
individu
contribut
influenza
rsv
aforement
diseas
burden
accur
influenza
rsv
cocircul
winter
season
burden
diseas
often
label
influenza
like
ill
ili
consid
primarili
compris
diseas
due
influenza
infect
howev
known
potenti
compris
variou
agent
inclus
rsv
identif
rel
contribut
virus
strongli
hamper
particular
even
viral
agent
adeno
parainfluenza
coronavirus
may
contribut
burden
ili
exactli
analys
burden
diseas
influenza
rsv
separ
goal
current
paper
ili
therefor
inappropri
concept
therefor
chose
analys
isol
exactli
relat
respect
causal
agent
given
potenti
complic
influenza
rsv
one
may
expect
excess
healthcar
resourc
util
epidem
studi
estim
excess
resourc
util
previous
direct
hospit
admiss
gpvisit
yet
hardli
inform
associ
occurr
influenza
rsv
use
medic
among
gener
popul
drugus
specif
complic
influenza
rsv
could
certainli
temporarili
elev
particular
prescript
antibiot
otolog
cardiovascular
medic
may
elev
dispens
otiti
media
cardiac
complic
respiratori
ill
pulmonari
complic
address
topic
investig
associ
weekli
report
rsv
influenza
isol
netherland
weekli
number
prescript
drug
dispens
dutch
pharmaci
particular
antibiot
otolog
cardiovascular
drug
prevent
point
view
high
influenzaassoci
drugus
may
justifi
extend
use
prevent
measur
influenza
vaccin
particular
may
enhanc
healtheconom
profil
extend
influenza
vaccin
current
yet
unvaccin
group
research
may
contribut
discuss
whether
exampl
young
children
vaccin
whether
age
limit
vaccin
program
lower
dutch
work
group
clinic
virolog
gather
data
laboratori
throughout
netherland
test
clinic
specimen
respiratori
virus
includ
rsv
influenza
b
number
patient
test
posit
rsv
influenza
report
weekli
basi
absenc
drastic
chang
recruit
test
specimen
weekli
time
seri
validli
conceiv
repres
actual
time
trend
without
requir
correct
appli
data
exclud
weekli
random
fluctuat
move
averag
use
present
fig
defin
specif
week
exhibit
elev
activ
influenza
rsv
two
method
defin
week
elev
activ
influenza
rsv
appli
first
method
defin
week
elev
activ
one
move
averag
two
time
gross
overal
averag
weekli
number
week
onward
week
week
obvious
week
januari
week
gener
consid
start
influenza
season
follow
jansen
et
al
second
method
defin
week
elev
activ
week
period
least
consecut
week
individu
week
account
season
total
number
influenzaor
rsvposit
specimen
method
appear
period
consist
number
subsequ
week
result
rather
individu
week
short
period
exampl
week
period
would
expect
inde
found
week
week
next
year
nonsumm
season
week
contain
influenza
rsv
activ
exclud
defin
period
elev
activ
given
difficulti
separ
individu
influenc
week
combin
activ
result
week
either
elev
influenza
rsv
analyz
furthermor
periseason
defin
contain
week
week
includ
week
next
year
belong
influenza
rsv
period
season
week
week
includ
week
label
summer
inform
drugus
popul
provid
univers
groningen
inhous
prescript
databas
wwwiadbnl
databas
iadbnl
contain
prescript
demograph
popul
data
person
adher
pharmaci
north
east
netherland
analyt
purpos
prescript
divid
age
categori
age
categori
year
divid
age
enabl
analysi
infant
separ
present
follow
categor
appli
exact
age
person
determin
everi
year
octob
close
period
netherland
invit
influenza
vaccin
risk
group
sent
gp
supposedli
prior
season
increas
risk
influenza
epidem
octob
onward
may
annual
total
popul
size
base
estim
januari
local
author
place
pharmaci
locat
person
receiv
one
studi
drug
divid
highrisk
lowrisk
group
influenza
respect
popul
belong
group
estim
use
prescript
proxi
medic
consist
highrisk
indic
specifi
dutch
health
council
dutch
gp
http
nhgartsennetnl
uniqu
prescrib
indic
exampl
dornas
alfa
drug
prescrib
cystic
fibrosi
includ
defin
person
respiratori
diseas
medic
cystic
fibrosi
acetylcystein
also
prescrib
cough
therefor
includ
tabl
list
drug
specif
heart
medic
diuret
sulfonamid
includ
diuret
use
lower
blood
pressur
exclud
highblood
pressur
highrisk
identifi
condit
furthermor
calcium
antagonist
atccod
includ
assum
cardiac
effect
beta
blocker
raa
system
agent
exclud
exclus
prescrib
cardiac
diseas
also
exampl
highblood
pressur
renal
diseas
medic
treatment
hyperkalemia
hyperphosphatemia
antianem
prepar
sulfonamid
includ
often
prescrib
dialysi
renal
insuffici
identifi
immunocompromis
patient
immunosuppress
includ
prescrib
exampl
patient
organ
transplant
also
hiv
medic
includ
also
hivpati
list
highrisk
group
mention
netherland
influenza
vaccin
recommend
increas
risk
complic
base
specif
medic
condit
determin
specif
patient
label
belong
highrisk
group
recommend
dutch
health
council
guidelin
dutch
gp
http
nhgartsennetnl
access
septemb
influenza
highrisk
indic
use
particular
person
label
belong
highrisk
group
two
prescript
group
medic
includ
list
two
differ
date
year
first
octob
latter
suppos
guarante
condit
would
chronic
specif
year
note
person
risk
statu
may
chang
year
year
popul
size
highrisk
group
subsequ
determin
octob
count
number
highrisk
person
iadbnl
rest
popul
assum
low
risk
specif
direct
analysi
drug
group
antibiot
otolog
cardiovascular
drug
drug
may
consid
complic
viral
infect
yet
publish
scientif
literatur
iadbnl
prescript
antibiot
atccod
otolog
atccod
medic
cardiovascular
system
atccod
c
select
antibiot
commonli
prescrib
treatment
acut
otiti
media
aom
particular
young
children
aom
account
approxim
half
antibiot
cours
deliv
otolog
may
also
prescrib
aom
despit
recommend
dutch
colleg
gener
practition
nhg
addit
averag
number
antibiot
may
prescrib
elderli
person
ili
period
elev
activ
particularli
group
may
develop
acut
respiratori
ill
exampl
pneumonia
complic
viral
infect
trimethoprim
nitrofurantoin
exclud
analysi
prescrib
primarili
urinari
tract
infect
antibiot
otolog
initi
next
prescript
within
year
consid
well
known
influenzarel
complic
preval
among
person
cardiovascular
chronic
diseas
person
without
underli
condit
person
year
older
highrisk
condit
increas
rate
hospitalis
cardiac
problem
report
recent
studi
suggest
might
also
associ
cardiovascular
problem
influenza
epidem
among
group
without
cardiovascular
histori
yet
elderli
even
among
age
year
age
analys
cardiovascular
medic
first
prescript
consid
current
interest
investig
whether
viral
infect
relat
new
cardiovascular
diseas
andor
exacerb
exist
yet
untreatedbackground
cardiovascular
condit
rather
identifi
chronic
medic
cardiovascular
diseas
note
chronic
cardiovascular
medic
use
use
criterion
assign
person
highrisk
group
prescript
defin
first
prescript
person
prescript
drug
drug
subgroup
year
specif
prescript
variou
period
elev
activ
determin
number
prescript
week
belong
influenza
rsv
periodsseason
compar
number
prescript
periseason
compar
purpos
also
result
compar
summer
season
present
done
everi
age
group
total
popul
highrisk
group
lowrisk
group
incid
rate
calcul
correspond
confid
interv
estim
incid
rate
calcul
weekli
number
prescript
per
personyear
p
number
prescript
week
season
influenza
rsv
peri
summer
n
number
week
specif
period
interest
n
popul
size
per
age
group
high
risk
low
risk
divis
transfer
personweek
estim
personyear
year
instead
use
microsoft
offic
excel
use
process
data
calcul
graphic
studi
period
averag
weekli
number
influenzaposit
rsvposit
specimen
respect
first
method
defin
period
elev
activ
use
two
time
averag
number
isol
per
week
lower
limit
influenza
rsv
result
tabl
show
week
label
belong
influenza
rsv
periand
summer
period
second
method
defin
period
elev
activ
least
two
consecut
week
week
account
season
total
number
rsvor
influenzaposit
specimen
yield
compar
result
data
shown
hereaft
result
method
differ
result
method
present
otherwis
result
first
method
shown
obvious
period
elev
activ
periseason
chang
year
year
length
summer
season
cours
alway
rang
week
includ
week
next
year
year
overlap
influenza
rsv
activ
week
seen
case
week
exclud
tabl
personyear
period
elev
activ
per
age
group
total
popul
highrisk
group
lowrisk
group
tabl
excess
drug
prescript
period
elev
activ
compar
periseason
shown
number
prescript
per
personyear
periseason
level
number
person
insuffici
valid
estim
result
statist
signific
b
although
borderlin
signific
shown
whole
agegroup
agegroup
specif
analys
reveal
signific
relat
signific
clinic
relev
surplu
age
categori
total
popul
lowrisk
group
respect
tabl
present
number
personyear
influenza
rsv
periseason
summer
period
per
age
risk
group
infant
children
age
highrisk
group
small
personyear
influenza
period
personyear
rsv
period
therefor
figur
lowand
highrisk
group
taken
togeth
use
age
furthermor
age
group
number
personyear
highrisk
group
lower
number
lowrisk
group
also
note
expect
older
age
group
contain
rel
personyear
highrisk
group
younger
age
group
fig
show
number
posit
find
rsv
influenza
per
week
annual
influenza
rsv
epidem
clearli
seen
overlap
year
also
number
first
prescript
per
person
antibiot
otolog
cardiovascular
medic
plot
total
popul
particular
antibiot
clear
pattern
visibl
influenza
rsv
activ
period
peak
antibiot
use
occur
addit
notic
younger
age
group
amoxicillin
mostli
prescrib
antibiot
wherea
age
group
onward
antibiot
mostli
prescrib
data
shown
excess
prescript
per
personyear
influenza
rsv
period
present
tabl
compar
periseason
note
method
use
estim
activ
period
show
similar
result
number
prescript
antibiot
significantli
elev
activ
period
age
group
age
group
excess
prescript
highest
rsv
period
older
age
group
surplus
higher
influenza
period
influenza
lowrisk
group
show
higher
excess
prescript
compar
highrisk
group
prescript
otolog
significantli
elev
period
elev
activ
howev
youngest
age
group
infant
children
age
year
contrast
antibiot
excess
prescript
higher
influenza
period
rsv
period
first
cardiovascular
medic
prescript
rate
rsv
period
lower
periseason
although
signific
influenza
period
higher
prescript
rate
found
age
year
older
age
group
analyz
age
categori
separ
also
signific
differ
age
categori
seen
fig
show
prescript
rate
per
personyear
confid
interv
select
aggreg
age
group
differ
period
per
year
separ
well
aggreg
year
incid
rate
antibiot
increas
influenza
rsv
period
comparison
periseason
summer
season
increas
notic
everi
year
otolog
incid
rate
increas
confid
interv
wide
therefor
everi
year
render
statist
signific
differ
influenza
rsv
period
first
cardiovascular
prescript
also
increas
notic
influenza
period
compar
periseason
everi
year
signific
differ
found
final
note
fig
elev
influenza
rsv
period
necessarili
follow
rel
lower
level
periandor
summer
season
suggest
surplus
detect
actual
extra
prescript
neutral
subsequ
dip
prescript
statist
signific
excess
antibiot
prescript
period
elev
activ
influenza
rsv
found
virus
age
group
year
investig
irrespect
method
use
exactli
defin
influenza
rsv
activ
period
otolog
influenza
rsvactiv
period
statist
signific
surplus
found
young
children
opposit
excess
cardiovascular
drug
prescript
identifi
adult
elderli
period
elev
influenza
activ
gener
found
tendenc
higher
percentag
surplus
lowrisk
group
highrisk
group
antibiot
cardiovascular
drug
probabl
explain
fact
individu
belong
highrisk
group
higher
likelihood
vaccin
influenza
lower
chanc
infect
secondari
bacteri
cardiovascular
complic
tendenc
also
appli
lowrisk
elderli
compar
highrisk
elderli
despit
fact
whole
group
recommend
vaccin
choic
research
note
specif
lower
limit
weekli
movingaverag
number
isol
week
label
activ
chosen
two
differ
method
first
use
cutoff
two
time
averag
number
influenza
rsv
isol
per
week
limit
chosen
achiev
continu
period
per
year
week
subsequ
label
activ
ie
guarante
epidem
period
rather
fluctuat
second
method
use
concord
previous
perform
dutch
studi
use
week
account
season
total
number
influenza
rsv
isol
gener
method
result
similar
result
use
influenza
rsv
activ
period
exclud
week
combin
activ
possibl
major
influenc
presenc
respect
viru
reduc
howev
exclus
week
influenza
rs
virus
activ
necessari
year
includ
analysi
also
methodolog
exclud
week
includ
count
personyear
effect
exclud
week
mayb
limit
yet
possibl
influenc
respiratori
viru
obvious
remain
present
howev
impact
virus
probabl
limit
may
long
period
margin
increas
activ
rather
clear
season
pattern
furthermor
complic
expect
milder
compar
influenza
rsv
infect
compar
data
activ
period
periseason
provid
conserv
estim
surplus
would
compar
summer
period
yet
underestim
surplus
may
introduc
way
feel
howev
comparison
periseason
appropri
potenti
influenc
concern
climat
possibl
virus
circul
nonsumm
period
probabl
compar
periseason
activ
period
everi
year
rsvposit
specimen
reach
rel
small
intens
peak
around
week
earlier
studi
shown
similar
tendenc
rsv
isol
peak
everi
year
around
time
suggest
presenc
potenti
common
strict
season
factor
might
increas
number
isol
prescript
howev
probabl
invalid
associ
surplus
found
analys
truli
seen
line
studi
person
label
belong
highrisk
group
base
specif
medic
profil
particular
person
belong
highrisk
group
select
base
prescript
correspond
rather
uniqu
highrisk
indic
prescript
potenti
meant
indic
label
high
risk
consist
exclud
still
possibl
select
criteria
unjustli
label
individu
belong
highrisk
group
also
individu
may
incorrectli
exclud
label
nonhighrisk
final
one
may
hypothes
excess
prescript
mere
shift
time
extra
prescript
later
outweigh
dip
prescript
sometim
refer
harvest
effect
visual
inspect
data
howev
give
reason
support
hypothesi
studi
addit
formal
statist
comparison
number
prescript
periseason
first
week
activ
season
show
peakdip
pattern
data
shown
previous
variou
investig
perform
associ
influenza
rsv
epidem
one
hand
hospitalis
mortal
outpati
visit
briefli
compar
outcom
know
valid
make
comparison
studi
limit
due
differ
outcom
measur
statist
model
studi
period
healthcar
system
concern
previous
one
studi
investig
excess
antibiot
use
influenzaact
period
gener
popul
studi
show
otherwis
healthi
children
get
prescript
antibiot
influenza
period
howev
surplu
report
rel
low
compar
find
two
studi
estim
excess
antibiot
prescript
rsv
influenzaact
season
focuss
specif
target
group
first
studi
focuss
patient
suffer
chronic
lung
diseas
show
highest
surplus
youngest
age
group
latter
studi
show
higher
surplus
due
influenza
compar
rsv
live
nurs
home
result
line
find
antibiot
sever
studi
indic
gener
rsv
influenzaact
period
infant
elderli
show
highest
morbid
mortal
rate
certainli
line
find
excess
antibiot
otolog
prescript
among
youngest
age
group
cardiovascular
medic
surplus
among
older
age
group
contrast
studi
show
higher
morbid
mortal
among
oldest
age
group
compar
nonelderli
adult
studi
show
elev
prescript
antibiot
oldest
age
group
year
age
older
higher
two
younger
age
group
yet
compar
adult
age
group
small
increas
could
seen
influenza
slightli
deviat
find
compar
nondutch
set
might
explain
high
vaccin
coverag
among
elderli
netherland
recent
dutch
studi
show
rsvrelat
excess
hospitalis
consider
higher
compar
due
influenza
compar
studi
perform
england
wale
show
greater
excess
rate
complic
rsvactiv
period
among
youngest
age
group
compar
influenza
similar
rate
found
age
group
five
studi
focuss
excess
morbid
mortal
hospitalis
among
children
confirm
result
show
rsv
respons
higher
hospitalis
rate
influenza
netherland
jansen
et
al
recent
show
excess
hospitalis
cardiovascular
complic
among
year
old
influenzaact
period
rsvactiv
period
line
find
show
signific
surplu
first
cardiovascular
medic
prescript
influenzaact
period
rsvactiv
period
age
year
elev
hospitalis
prescript
rate
influenza
period
person
age
around
year
beyond
suggest
influenza
may
caus
cardiovascular
diseas
may
aggrav
exist
nondiagnos
cardiovascular
diseas
older
adult
anoth
hypothesi
explain
increas
might
increas
cardiovascular
problem
influenza
period
relat
increas
use
analges
period
allevi
influenza
symptom
research
definit
need
topic
thu
gener
result
seem
compar
studi
relat
elev
viral
activ
use
healthcar
resourc
morbid
mortal
studi
consist
show
highest
excess
rate
youngest
age
group
mostli
due
rsv
wherea
influenza
seen
elderli
vaccin
may
prevent
part
excess
prescript
found
exampl
healthi
children
recommend
vaccin
influenza
netherland
vaccin
might
prevent
part
surplu
prescript
found
group
particular
vaccin
may
prevent
influenza
infect
potenti
subsequ
bacteri
super
infect
thu
avert
antibiot
prescrib
prevent
treatment
bacteri
super
infect
addit
reduc
prescript
antibiot
may
also
import
perspect
limit
develop
antibiot
resist
reason
could
addit
motiv
vaccin
yet
uncov
group
influenza
effect
vaccin
rsv
may
potenti
even
prevent
antibiot
prescript
especi
young
children
yet
introduct
vaccin
rsv
expect
near
futur
influenzaand
rsvactiv
period
elev
antibiot
prescript
identifi
age
group
otolog
elev
shown
age
group
year
influenzaand
rsvactiv
season
vaccin
young
children
influenza
part
prescript
antibiot
otolog
may
prevent
person
year
older
elev
prescript
cardiovascular
medic
shown
period
elev
influenza
activ
particular
lowrisk
popul
also
antibiot
prescript
excess
found
higher
lowrisk
popul
highrisk
popul
possibl
indic
effect
vaccin
program
highrisk
group
rel
high
coverag
rate
reach
netherland
